NovaBay Pharmaceuticals Inc. (NBY) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2026-01-29
7:38 pm
Purchase		2025-10-2113DNovaBay Pharmaceuticals, Inc.
NBY		Lazar David E.1,277,600
4.990%		977,184increase
(+325.28%)		Filing
History
2026-01-21
8:12 pm
Unchanged		2026-01-1613DNovaBay Pharmaceuticals, Inc.
NBY		Framework Ventures IV L.P.11,361,216
45.000%		0
(Unchanged)		Filing
History
2026-01-21
8:11 pm
Unchanged		2026-01-1613DNovaBay Pharmaceuticals, Inc.
NBY		R01 Fund LP11,361,216
45.000%		0
(Unchanged)		Filing
History
2025-10-20
9:42 pm
Purchase		2025-10-1613DNovaBay Pharmaceuticals, Inc.
NBY		R01 Fund LP11,361,216
45.100%		11,128,393increase
(+4779.76%)		Filing
History
2025-10-20
9:42 pm
Purchase		2025-10-1613DNovaBay Pharmaceuticals, Inc.
NBY		Framework Ventures IV L.P.11,361,216
45.100%		11,128,393increase
(+4779.76%)		Filing
History
2025-10-17
5:29 pm
Purchase		2025-10-1613DNovaBay Pharmaceuticals, Inc.
NBY		Lazar David E.300,416
19.990%		60,406increase
(+25.17%)		Filing
History
2025-10-17
5:10 pm
Unchanged		2025-10-1513DNovaBay Pharmaceuticals, Inc.
NBY		Poplar Point Capital Management LLC204,060
17.520%		0
(Unchanged)		Filing
History
2025-10-15
8:29 pm
Purchase		2025-10-0913DNovaBay Pharmaceuticals, Inc.
NBY		R01 Fund LP232,823
16.200%		232,823increase
(New Position)		Filing
History
2025-10-15
8:28 pm
Purchase		2025-10-0913DNovaBay Pharmaceuticals, Inc.
NBY		Framework Ventures IV L.P.232,823
16.200%		232,823increase
(New Position)		Filing
History
2025-09-04
7:21 pm
Unchanged		2025-09-0313DNovaBay Pharmaceuticals, Inc.
NBY		Poplar Point Capital Management LLC204,060
17.520%		0
(Unchanged)		Filing
History
2025-08-26
4:11 pm
Purchase		2025-08-1913DNovaBay Pharmaceuticals, Inc.
NBY		Lazar David E.240,010
19.990%		240,010increase
(New Position)		Filing
History
2025-06-04
12:46 pm
Purchase		2025-06-0313DNovaBay Pharmaceuticals, Inc.
NBY		Poplar Point Capital Management LLC204,060
17.540%		9,729increase
(+5.01%)		Filing
History
2025-05-15
09:00 am
Purchase		2025-03-3113GNovaBay Pharmaceuticals, Inc.
NBY		Poplar Point Capital Management LLC194,331
16.710%		70,194increase
(+56.55%)		Filing
History
2025-02-06
6:30 pm
Purchase		2025-01-3113GNovaBay Pharmaceuticals, Inc.
NBY		Poplar Point Capital Management LLC124,137
12.700%		48,478increase
(+64.07%)		Filing
History
2025-01-10
6:06 pm
Purchase		2024-12-3113GNovaBay Pharmaceuticals, Inc.
NBY		Poplar Point Capital Management LLC75,659
7.700%		75,659increase
(New Position)		Filing
History
2024-11-08
5:31 pm
Unchanged		2024-09-3013GNovaBay Pharmaceuticals, Inc.
NBY		Hudson Bay Capital Management LP0
0.000%		0
(Unchanged)		Filing
History
2024-02-14
2:52 pm
Purchase		2023-12-3113GNovaBay Pharmaceuticals, Inc.
NBY		Armistice Capital, LLC2,177
4.990%		1,081increase
(+98.59%)		Filing
History
2024-02-13
5:17 pm
Purchase		2023-12-3113GNovaBay Pharmaceuticals, Inc.
NBY		Altium Capital Management LLC3,626
4.990%		3,626increase
(New Position)		Filing
History
2024-02-06
11:52 am
Purchase		2023-12-3113GNovaBay Pharmaceuticals, Inc.
NBY		Hudson Bay Capital Management LP4,107
9.990%		2,816increase
(+218.13%)		Filing
History
2023-02-14
1:11 pm
Purchase		2022-12-3113GNovaBay Pharmaceuticals, Inc.
NBY		Armistice Capital, LLC1,096
9.990%		1,096increase
(New Position)		Filing
History
Goto 0, 1, Next